Interim Financial Information - Narrative (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
Dec. 31, 2012 |
Dec. 31, 2011 |
|
| Quarterly Financial Information Disclosure [Abstract] | ||||||||||||||
| Loss (gain) on Convertible Debt Derivatives, Net of Tax | $ 1,014,000 | $ 1,192,000 | $ 486,000 | $ 604,000 | ||||||||||
| Loss (gain) on Convertible Debt Derivatives, Per Diluted Share | $ 0.03 | $ 0.04 | $ 0.02 | $ 0.02 | ||||||||||
| Gain (Loss) on Disposition of Business, Net of Tax | $ 7,386,000 | |||||||||||||
| Gain (Loss) from Disposition of Business, Net of Tax, Per Diluted Share | $ 0.23 | |||||||||||||
| Charges | $ 1,148,000 | $ 508,000 | $ 689,000 | $ 102,000 | $ 1,031,000 | $ 689,000 | $ 240,000 | $ 2,447,000 | $ 1,971,000 | $ 11,112,000 | $ 9,336,000 | $ 11,395,000 | $ 10,534,000 | |
| Restructuring charges, net of tax | $ 1,148,000 | $ 508,000 | $ 689,000 | $ 102,000 | $ 957,000 | $ 635,000 | $ 240,000 | |||||||
| Restructuring charges, net of tax, per diluted share | $ 0.04 | $ 0.02 | $ 0.02 | $ 0.00 | $ 0.03 | $ 0.02 | $ 0.01 | |||||||
| Loss (gain) on Convertible Debt Derivatives | $ 1,014,000 | $ 1,192,000 | $ 486,000 | $ 604,000 | (1,268,000) | 0 | 0 | |||||||
| Gain on sale of business (pre-tax) | $ (7,386,000) | 7,386,000 | 24,000 | 0 | ||||||||||
| Product Warranty Expense | 1,670,000 | 1,220,000 | $ 2,325,000 | |||||||||||
| Product Warranty Expense, Net of Tax | $ 1,670,000 | $ 1,220,000 | $ 2,325,000 | |||||||||||
| Product warranty expense, net of tax, per diluted share | $ 0.05 | $ 0.04 | $ 0.07 | |||||||||||
| Write off of debt fees | $ 668,000 | |||||||||||||
| Write off of debt fees, net of tax | $ 668,000 | |||||||||||||
| Write off of debt fees per diluted share | $ 0.02 | |||||||||||||
| Tax benefit (expense) from intra-period allocation | $ 3,400,000 | (140,000) | (7,175,000) | |||||||||||
| Tax benefit (expense) from intra-period allocation per diluted share | $ 0.11 | |||||||||||||
| Loss Contingency Accrual, Period Increase (Decrease) | $ 2,856,000 | $ (2,325,000) | $ 11,493,000 | |||||||||||